Sign In
Buy TTOO
$0.0005
+0 (+0%)
At Close: Jul 31, 2026
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
09:00am, Thursday, 28'th Mar 2024
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced tha
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
07:30am, Wednesday, 20'th Mar 2024
Anticipates commercial launch of the T2Lyme Panel in the third quarter of 2024 Anticipates commercial launch of the T2Lyme Panel in the third quarter of 2024
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
09:00am, Tuesday, 19'th Mar 2024
LEXINGTON, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
09:00am, Monday, 18'th Mar 2024
Study demonstrates T2Resistance Panel utilization enables faster targeted therapy based on direct-from-blood detection of resistance genes Study demonstrates T2Resistance Panel utilization enables fas
TTOO Stock: T2 Biosystems Has Until May 20 to Regain Nasdaq Compliance
03:16pm, Tuesday, 12'th Mar 2024
Shares of T2 Biosystems (NASDAQ: TTOO ) stock are rising higher after the medical diagnostics company disclosed that the Nasdaq Hearings Panel had provided it with an extension to regain compliance. T
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
09:00am, Tuesday, 12'th Mar 2024
LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced th
T2 Biosystems (TTOO) share price stays stable post Q4 earnings
11:09am, Friday, 16'th Feb 2024
T2 Biosystems Inc. (TTOO), a prominent player in the field of medical diagnostics, recently announced its financial results for the fourth quarter of 2023, signaling a pivotal moment for the company.
T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript
07:37pm, Thursday, 15'th Feb 2024
T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
04:06pm, Thursday, 15'th Feb 2024
Advanced multiple new products and achieved record fourth quarter U.S. T2Bacteria Panel sales Advanced multiple new products and achieved record fourth quarter U.S. T2Bacteria Panel sales
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
04:04pm, Thursday, 15'th Feb 2024
LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
04:02pm, Thursday, 15'th Feb 2024
LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the e
T2 Biosystems Receives 510(K) Clearance for Its Bacteria Panel
12:12pm, Monday, 12'th Feb 2024
Shares of T2 Biosystems (NASDAQ: TTOO ) are jumping higher by more than 30%. This comes as the diagnostics company announced that it had received U.S. Food and Drug Administration (FDA) 510(k) cleara
T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024
04:05pm, Wednesday, 07'th Feb 2024
LEXINGTON, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today tha
T2 Biosystems (TTOO) stock price volatility has died: buy the dip?
09:35am, Monday, 13'th Nov 2023
T2 Biosystems (NASDAQ: TTOO) stock price has collapsed to a record low as concerns about the company's future continued. Shares of the popular penny stock have collapsed to a split-adjusted low of $4.
TTOO Stock Alert: T2 Biosystems Regains Nasdaq Compliance
01:02pm, Wednesday, 01'st Nov 2023
T2 Biosystems (NASDAQ: TTOO ) stock is in the green after the medical diagnostics company announced that it had received written notice from the Nasdaq Listing Qualifications Staff on Oct. 31 that it
